It was validated in the setting of mild cognitive impairment (MCI), and has subsequently been adopted in numerous other clinical settings. 1 It was created in 1996 by Ziad Nasreddine in Montreal, Quebec. Percentile distributions are presented that allow for age, education and sexĪdjustment for the MoCA Total Score and the MIS. The Montreal Cognitive Assessment ( MoCA) is a widely used screening assessment for detecting cognitive impairment. R 2 = 0.4, Marginal R 2 = 0.12, restricted maximum likelihood (REML) criterion at convergence: 3470.1) and MIS (Marginal R 2 = 0.14, REML criterion at convergence: 682.8). (3) Results: Age, education level, and sex were significant predictors of the MoCA Total Score (Conditional Papers which met inclusion and exclusion criteria were chosen to be included in this review. Conclusion The MoCA-BC is a reliable cognitive screening test across all education levels in Chinese elderly adults, with high acceptance and good reliability. Were computed for the MoCA Total Score and MIS, following the data-handling procedure of the Advanced Neuropsychological Diagnostics The following medical subject headings were used in the search: mild cognitive impairment, mini-mental state examination, Montreal cognitive assessment, diagnostics value. The MoCA-BC was superior to the MMSE for detecting MCI, with optimal sensitivity and specificity across all education groups using the above cutoff scores. Montreal Cognitive Assessment is therefore a useful and mostly accurate tool for identifying dementia. This means 94 percent of people who have dementia scored less than 26 out of 30 on MoCA (25 and under is considered at-risk). Ziad S Nasreddine, Natalie Phillips, Howard Chertkow. Methods: A total of 820 healthy individuals aged 18-91 (366 men) completed the Dutch MoCA (version 7.1), of whom 182 alsoĬompleted the cued recall and recognition memory subtests enabling calculation of the MIS. Studies have found MoCA to be about 94 percent accurate in telling whether a person has dementia or not. Normative data for the Montreal Cognitive Assessment (MoCA) in a population-based sample. However, fine-grained normativeĭata allowing for adjustment for age, education, and/or sex are lacking, especially for its Memory Index Score (MIS). Conclusions: The MoCA is a valid estimate of daily life functional autonomy in non-demented PD patients, also reflecting apathetic features of a dysexecutive nature.(1) Background: There is a need for a brief assessment of cognitive function, both in patient care and scientific research,įor which the Montreal Cognitive Assessment (MoCA) is a psychometrically reliable and valid tool. The Relation Between ADHD Medication and Mild Cognitive Impairment, as Assessed by the Montreal Cognitive Assessment (MoCA), in Patients Entering Substance Use Disorder Inpatient Treatment J Dual Diagn. Results: MoCA scores were significantly associated with the SES ( r s(73) = 0.34 p = 0.005) and the DAS-Executive ( r(67) = −0.47 p < 0.001), while not to other FI/BP outcomes and QoL measures. This study examined the psychometric properties and the validity of the Taiwan version of the MoCA (MoCA-T) in an elderly outpatient population. Intake of psychotropic drugs was also covaried when assessing the association between the MoCA and BP/QoL measures. The Montreal Cognitive Assessment (MoCA) is a cognitive screening instrument developed to detect mild cognitive impairment (MCI). Background: The Montreal Cognitive Assessment (MoCA) is an instrument for screening mild cognitive impairment (MCI). Associations of interest against FI, QoL, and BP outcomes were tested via Bonferroni-corrected Pearson’s/Spearman’s correlations while covarying for demographics, disease duration as well as UPDRS-III, UPDRS-IV, and HY scores. Methods: Seventy-four non-demented PD patients were administered the MoCA and underwent motor functional – i.e., Unified Parkinson’s Disease Rating Scale (UPDRS), Modified Hoehn-Yahr Scale (HY), and Schwab and England Scale (SES) –, behavioural and psychological – i.e., State- and Trait-Anxiety Inventory-Form Y (STAI-Y1/-Y2), Beck Depression Inventory (BDI), and Dimensional Apathy Scale (DAS) – and QoL evaluations – i.e., MOS 36-Item Short Form Health Survey (SF-36). Objectives: The objective of this study was to examine, within an Italian cohort of non-demented Parkinson’s disease (PD) patients, the ecological validity of the Montreal Cognitive Assessment (MoCA) by assessing its association with (1) functional independence (FI), (2) quality of life (QoL), and (3) behavioural-psychological (BP) outcomes. Background: The ecological validity of performance-based cognitive screeners needs to be tested in order for them to be fully recommended for use within clinical practice and research.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |